Boston Scientific | BSX - Des Atouts





Des Atouts Changement Date
Abbott USD 108.25B 968M 2026-09
AtriCure USD 717.54M 40.89M 2026-09
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Boston Scientific USD 45.46B 245M 2026-09
CONMED USD 2.3B 4.16M 2026-09
Cooper Companies USD 12.67B 191.1M 2026-06
Danaher USD 93.28B 914M 2026-09
Dexcom USD 6.24B 216.5M 2026-09
Edwards Lifesciences USD 14.14B 277.3M 2026-09
Globus Medical USD 5.53B 39.93M 2026-09
Illumina USD 6.81B 162M 2026-09
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.42B 250M 2026-09
Integra LifeSciences USD 3.51B 55.69M 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merit Medical Systems USD 2.92B 61.29M 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.16B 5.29M 2026-09
Teleflex USD 6.35B 438.92M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09